首页 > 最新文献

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry最新文献

英文 中文
Antioxidant Effects of Oleuropein on Hydrogen Peroxide-Induced Neuronal Stress- An In Vitro Study. 橄榄苦苷对过氧化氢诱导的神经元应激的体外抗氧化作用研究。
Q2 Medicine Pub Date : 2020-01-01 DOI: 10.2174/1871523018666190201145824
Altug Kucukgul, Mehmet M Isgor, Vesile Duzguner, Meryem N Atabay, Azime Kucukgul

Background: Persistent oxidative stress can lead to chronic inflammation and mediate most chronic diseases including neurological disorders. Oleuropein has been shown to be a potent antioxidant molecule in olive oil leaf having antioxidative properties.

Objective: The aim of this study was to investigate the protective effects of oleuropein against oxidative stress in human glioblastoma cells.

Methods: Human glioblastoma cells (U87) were pretreated with oleuropein (OP) essential oil 10 µM. After 30 minutes, 100 µM H2O2 was added to the cells for three hours. Cell survival was quantified by colorimetric MTT assay. Glutathione level, total oxidant capacity, total antioxidant capacity and nitric oxide levels were determined by using specific spectrophotometric methods. The relative gene expression level of iNOS was performed by qRT-PCR method.

Results: According to viability results, the effective concentration of H2O2 (100µM) significantly decreased cell viability and oleuropein pretreatment significantly prevented the cell losses. Oleuropein regenerated total antioxidant capacity and glutathione levels decreased by H2O2 exposure. In addition, nitric oxide and total oxidant capacity levels were also decreased after administration of oleuropein in treated cells.

Conclusion: Oleuropein was found to have potent antioxidative properties in human glioblastoma cells. However, further studies and validations are needed in order to understand the exact neuroprotective mechanism of oleuropein.

背景:持续氧化应激可导致慢性炎症并介导包括神经系统疾病在内的大多数慢性疾病。橄榄苦苷已被证明是橄榄油叶中一种有效的抗氧化分子,具有抗氧化特性。目的:探讨橄榄苦苷对人胶质母细胞瘤细胞氧化应激的保护作用。方法:用橄榄苦苷(OP)精油10µM预处理人胶质瘤细胞(U87)。30分钟后,向细胞中加入100µM H2O2 3小时。采用比色MTT法测定细胞存活率。采用分光光度法测定血清谷胱甘肽水平、总氧化能力、总抗氧化能力和一氧化氮水平。采用qRT-PCR法检测iNOS基因的相对表达量。结果:活性结果显示,H2O2有效浓度(100µM)显著降低细胞活力,橄榄苦苷预处理显著防止细胞损失。橄榄苦苷再生总抗氧化能力和谷胱甘肽水平降低H2O2暴露。此外,橄榄苦苷也降低了处理细胞的一氧化氮和总氧化能力水平。结论:橄榄苦苷对人胶质母细胞瘤细胞具有较强的抗氧化作用。然而,橄榄苦苷的神经保护机制还需要进一步的研究和验证。
{"title":"Antioxidant Effects of Oleuropein on Hydrogen Peroxide-Induced Neuronal Stress- An <i>In Vitro</i> Study.","authors":"Altug Kucukgul,&nbsp;Mehmet M Isgor,&nbsp;Vesile Duzguner,&nbsp;Meryem N Atabay,&nbsp;Azime Kucukgul","doi":"10.2174/1871523018666190201145824","DOIUrl":"https://doi.org/10.2174/1871523018666190201145824","url":null,"abstract":"<p><strong>Background: </strong>Persistent oxidative stress can lead to chronic inflammation and mediate most chronic diseases including neurological disorders. Oleuropein has been shown to be a potent antioxidant molecule in olive oil leaf having antioxidative properties.</p><p><strong>Objective: </strong>The aim of this study was to investigate the protective effects of oleuropein against oxidative stress in human glioblastoma cells.</p><p><strong>Methods: </strong>Human glioblastoma cells (U87) were pretreated with oleuropein (OP) essential oil 10 µM. After 30 minutes, 100 µM H2O2 was added to the cells for three hours. Cell survival was quantified by colorimetric MTT assay. Glutathione level, total oxidant capacity, total antioxidant capacity and nitric oxide levels were determined by using specific spectrophotometric methods. The relative gene expression level of iNOS was performed by qRT-PCR method.</p><p><strong>Results: </strong>According to viability results, the effective concentration of H2O2 (100µM) significantly decreased cell viability and oleuropein pretreatment significantly prevented the cell losses. Oleuropein regenerated total antioxidant capacity and glutathione levels decreased by H2O2 exposure. In addition, nitric oxide and total oxidant capacity levels were also decreased after administration of oleuropein in treated cells.</p><p><strong>Conclusion: </strong>Oleuropein was found to have potent antioxidative properties in human glioblastoma cells. However, further studies and validations are needed in order to understand the exact neuroprotective mechanism of oleuropein.</p>","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871523018666190201145824","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36924493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Psoralen Derivatives: Recent Advances of Synthetic Strategy and Pharmacological Properties. 补骨脂素衍生物:合成策略和药理特性的最新进展。
Q2 Medicine Pub Date : 2020-01-01 DOI: 10.2174/1871523018666190625170802
Joazaizulfazli Jamalis, Faten Syahira Mohamed Yusof, Subhash Chander, Roswanira Abd Wahab, Deepak P Bhagwat, Murugesan Sankaranarayanan, Faisal Almalki, Taibi Ben Hadda

Psoralen or furocoumarin is a linear three ring heterocyclic compound. Psoralens are planar, tricyclic compounds, consisting of a furan ring fused to a coumarin moiety. Psoralen has been known for a wide spectrum of biological activities, spanning from cytotoxic, photosensitizing, insecticidal, antibacterial to antifungal effect. Thus, several structural changes were introduced to explore the role of specific positions with respect to the biological activity. Convenient approaches utilized for the synthesis of psoralen skeleton can be categorized into two parts: (i) the preparation of the tricyclic ring system from resorcinol, (ii) the exocyclic modification of the intact ring system. Furthermore, although psoralens have been used in diverse ways, we mainly focus in this work on their clinical utility for the treatment of psioraisis, vitiligo and skin-related disorder.

补骨脂素或呋喃香豆素是一种线性三环杂环化合物。补骨脂素是平面三环化合物,由一个呋喃环和一个香豆素分子融合而成。补骨脂素具有广泛的生物活性,包括细胞毒性、光敏性、杀虫、抗菌和抗真菌作用。因此,我们引入了几种结构变化,以探索特定位置对生物活性的作用。合成补骨脂素骨架的便捷方法可分为两部分:(i) 从间苯二酚制备三环系统;(ii) 对完整的环系统进行外环修饰。此外,虽然补骨脂素的用途多种多样,但我们在这项工作中主要关注其在治疗银屑病、白癜风和皮肤相关疾病方面的临床用途。
{"title":"Psoralen Derivatives: Recent Advances of Synthetic Strategy and Pharmacological Properties.","authors":"Joazaizulfazli Jamalis, Faten Syahira Mohamed Yusof, Subhash Chander, Roswanira Abd Wahab, Deepak P Bhagwat, Murugesan Sankaranarayanan, Faisal Almalki, Taibi Ben Hadda","doi":"10.2174/1871523018666190625170802","DOIUrl":"10.2174/1871523018666190625170802","url":null,"abstract":"<p><p>Psoralen or furocoumarin is a linear three ring heterocyclic compound. Psoralens are planar, tricyclic compounds, consisting of a furan ring fused to a coumarin moiety. Psoralen has been known for a wide spectrum of biological activities, spanning from cytotoxic, photosensitizing, insecticidal, antibacterial to antifungal effect. Thus, several structural changes were introduced to explore the role of specific positions with respect to the biological activity. Convenient approaches utilized for the synthesis of psoralen skeleton can be categorized into two parts: (i) the preparation of the tricyclic ring system from resorcinol, (ii) the exocyclic modification of the intact ring system. Furthermore, although psoralens have been used in diverse ways, we mainly focus in this work on their clinical utility for the treatment of psioraisis, vitiligo and skin-related disorder.</p>","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/af/2a/AIAAMC-19-222.PMC7499361.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37370363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Inflammatory Profile on Selenium Levels in Hemodialysis Patients. 血液透析患者的炎症特征对硒水平的影响
Q2 Medicine Pub Date : 2020-01-01 DOI: 10.2174/1871523018666190121165902
Marcelo R Bacci, Lívia S S Cabral, Glaucia L da Veiga, Beatriz da C A Alves, Neif Murad, Fernando L A Fonseca

Introduction: Hemodialysis stands out as an eligible treatment for patients with chronic kidney disease. The subsequent inflammatory process resulting from this disease and hemodialysis per se is exacerbated in this therapy. Selenium (Se) is an essential trace element that can participate in the inhibition of pro-oxidant and pro-inflammatory processes and could be considered a measurement that indicates the progression of chronic kidney disease and inflammation.

Objectives: The present study investigated selenemia in hemodialysis patients of the ABC region of São Paulo and aimed to establish the correlation between an inflammatory marker and selenemia in this conditions disease.

Methods: This is an observational cross-sectional study of the Faculdade de Medicina do ABC in patients submitted to hemodialysis three times a week for at least six months. The eligible group composed of 21 patients, who filled out forms and underwent biochemical tests (colorimetric enzyme methods, flow cytometer, turbidimetric method and mass spectrometry).

Results: The study population showed, women (70%), men (30%) with a mean age of 47 ± 17 years, Caucasians (36%) and non-Caucasian (64%), hypertensive (68%), smokers (53%) and non-smokers (64%). There was a hegemonic prevalence of systolic arterial hypertension (SAH) 68.1% in relation to diabetes mellitus (DM) (50%). Pre and post hemodialysis (HD) selenemia showed statistical significance, which did not occur with Creactive protein. There was a predominance of females in our sample; the pre- and post- HD selenemia were within the normal range of the reference values; there was a statistically significant correlation between pre and post-HD selenemia; there was no correlation with statistical significance between values of pre and post-HD C-reactive protein.

Conclusion: Our data showed that there was no direct relationship between pre- and post- HD inflammation and pre- and post-HD selenemia.

简介血液透析是慢性肾病患者的首选治疗方法。这种疾病和血液透析本身导致的炎症过程在治疗过程中会加剧。硒(Se)是一种人体必需的微量元素,可参与抑制促氧化和促炎症过程,并可被视为显示慢性肾病和炎症进展的一种测量指标:本研究对圣保罗 ABC 地区血液透析患者的硒血症进行了调查,旨在确定这种疾病的炎症标志物与硒血症之间的相关性:本研究是一项观察性横断面研究,研究对象是每周进行三次血液透析且至少持续六个月的圣保罗ABC医学院患者。符合条件的 21 名患者填写了表格,并接受了生化检验(比色酶法、流式细胞仪、浊度法和质谱法):研究对象包括女性(70%)、男性(30%),平均年龄为 47 ± 17 岁,白种人(36%)和非白种人(64%),高血压患者(68%),吸烟者(53%)和非吸烟者(64%)。收缩期动脉高血压(SAH)的发病率为 68.1%,而糖尿病(DM)的发病率为 50%。血液透析(HD)前后的硒血症具有统计学意义,而 Creactive 蛋白则没有这种意义。我们的样本中女性居多;血液透析前和透析后的硒血症均在参考值的正常范围内;血液透析前和透析后的硒血症之间有统计学意义的相关性;血液透析前和透析后的C反应蛋白之间没有统计学意义的相关性:我们的数据显示,高密度脂蛋白血症前后的炎症与高密度脂蛋白血症前后的硒血症之间没有直接关系。
{"title":"The Impact of Inflammatory Profile on Selenium Levels in Hemodialysis Patients.","authors":"Marcelo R Bacci, Lívia S S Cabral, Glaucia L da Veiga, Beatriz da C A Alves, Neif Murad, Fernando L A Fonseca","doi":"10.2174/1871523018666190121165902","DOIUrl":"10.2174/1871523018666190121165902","url":null,"abstract":"<p><strong>Introduction: </strong>Hemodialysis stands out as an eligible treatment for patients with chronic kidney disease. The subsequent inflammatory process resulting from this disease and hemodialysis per se is exacerbated in this therapy. Selenium (Se) is an essential trace element that can participate in the inhibition of pro-oxidant and pro-inflammatory processes and could be considered a measurement that indicates the progression of chronic kidney disease and inflammation.</p><p><strong>Objectives: </strong>The present study investigated selenemia in hemodialysis patients of the ABC region of São Paulo and aimed to establish the correlation between an inflammatory marker and selenemia in this conditions disease.</p><p><strong>Methods: </strong>This is an observational cross-sectional study of the Faculdade de Medicina do ABC in patients submitted to hemodialysis three times a week for at least six months. The eligible group composed of 21 patients, who filled out forms and underwent biochemical tests (colorimetric enzyme methods, flow cytometer, turbidimetric method and mass spectrometry).</p><p><strong>Results: </strong>The study population showed, women (70%), men (30%) with a mean age of 47 ± 17 years, Caucasians (36%) and non-Caucasian (64%), hypertensive (68%), smokers (53%) and non-smokers (64%). There was a hegemonic prevalence of systolic arterial hypertension (SAH) 68.1% in relation to diabetes mellitus (DM) (50%). Pre and post hemodialysis (HD) selenemia showed statistical significance, which did not occur with Creactive protein. There was a predominance of females in our sample; the pre- and post- HD selenemia were within the normal range of the reference values; there was a statistically significant correlation between pre and post-HD selenemia; there was no correlation with statistical significance between values of pre and post-HD C-reactive protein.</p><p><strong>Conclusion: </strong>Our data showed that there was no direct relationship between pre- and post- HD inflammation and pre- and post-HD selenemia.</p>","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/47/73/AIAAMC-19-42.PMC7460750.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36883235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients. 在骨关节炎患者的随机双盲试验中,联合葡萄糖胺和软骨素与塞来昔布的血清生物标志物差异
Q2 Medicine Pub Date : 2020-01-01 DOI: 10.2174/1871523018666190115094512
Sandi L Navarro, Marta Herrero, Helena Martinez, Yuzheng Zhang, Jon Ladd, Edward Lo, David Shelley, Timothy W Randolph, Johanna W Lampe, Paul D Lampe

Background: Non-steroidal anti-inflammatory drugs, e.g., celecoxib, are commonly used for inflammatory conditions, but can be associated with adverse effects. Combined glucosamine hydrochloride plus chondroitin sulfate (GH+CS) are commonly used for joint pain and have no known adverse effects. Evidence from in vitro, animal and human studies suggest that GH+CS have anti-inflammatory activity, among other mechanisms of action.

Objective: We evaluated the effects of GH+CS versus celecoxib on a panel of 20 serum proteins involved in inflammation and other metabolic pathways.

Methods: Samples were from a randomized, parallel, double-blind trial of pharmaceutical grade 1500 mg GH + 1200 mg CS (n=96) versus 200 mg celecoxib daily (n=93) for 6- months in knee osteoarthritis (OA) patients. Linear mixed models adjusted for age, sex, body mass index, baseline serum protein values, and rescue medicine use assessed the intervention effects of each treatment arm adjusting for multiple testing.

Results: All serum proteins except WNT16 were lower after treatment with GH+CS, while about half increased after celecoxib. Serum IL-6 was significantly reduced (by 9%, P=0.001) after GH+CS, and satisfied the FDR<0.05 threshold. CCL20, CSF3, and WNT16 increased after celecoxib (by 7%, 9% and 9%, respectively, P<0.05), but these serum proteins were no longer statistically significant after controlling for multiple testing.

Conclusion: The results of this study using samples from a previously conducted trial in OA patients, demonstrate that GH+CS reduces circulating IL-6, an inflammatory cytokine, but is otherwise comparable to celecoxib with regard to effects on other circulating protein biomarkers.

背景:非甾体抗炎药,如塞来昔布,通常用于炎症,但可能与不良反应相关。盐酸氨基葡萄糖加硫酸软骨素(GH+CS)联合治疗关节疼痛常用,无已知不良反应。来自体外、动物和人体研究的证据表明,GH+CS具有抗炎活性,以及其他作用机制。目的:我们评估GH+CS与塞来昔布对20种参与炎症和其他代谢途径的血清蛋白的影响。方法:样本来自一项随机,平行,双盲试验,药物级1500mg GH + 1200mg CS (n=96)与200mg塞来昔布(n=93)每天6个月的膝关节骨关节炎(OA)患者。调整了年龄、性别、体重指数、基线血清蛋白值和急救药物使用的线性混合模型评估了经多重检验调整的每个治疗组的干预效果。结果:GH+CS治疗后除WNT16外,其余血清蛋白均降低,塞来昔布治疗后约有一半血清蛋白升高。GH+CS后血清IL-6显著降低(9%,P=0.001),满足fdr结论:本研究使用了先前在OA患者中进行的试验样本,结果表明GH+CS降低了循环IL-6,一种炎症细胞因子,但在其他循环蛋白生物标志物方面与塞来昔布相当。
{"title":"Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients.","authors":"Sandi L Navarro,&nbsp;Marta Herrero,&nbsp;Helena Martinez,&nbsp;Yuzheng Zhang,&nbsp;Jon Ladd,&nbsp;Edward Lo,&nbsp;David Shelley,&nbsp;Timothy W Randolph,&nbsp;Johanna W Lampe,&nbsp;Paul D Lampe","doi":"10.2174/1871523018666190115094512","DOIUrl":"https://doi.org/10.2174/1871523018666190115094512","url":null,"abstract":"<p><strong>Background: </strong>Non-steroidal anti-inflammatory drugs, e.g., celecoxib, are commonly used for inflammatory conditions, but can be associated with adverse effects. Combined glucosamine hydrochloride plus chondroitin sulfate (GH+CS) are commonly used for joint pain and have no known adverse effects. Evidence from in vitro, animal and human studies suggest that GH+CS have anti-inflammatory activity, among other mechanisms of action.</p><p><strong>Objective: </strong>We evaluated the effects of GH+CS versus celecoxib on a panel of 20 serum proteins involved in inflammation and other metabolic pathways.</p><p><strong>Methods: </strong>Samples were from a randomized, parallel, double-blind trial of pharmaceutical grade 1500 mg GH + 1200 mg CS (n=96) versus 200 mg celecoxib daily (n=93) for 6- months in knee osteoarthritis (OA) patients. Linear mixed models adjusted for age, sex, body mass index, baseline serum protein values, and rescue medicine use assessed the intervention effects of each treatment arm adjusting for multiple testing.</p><p><strong>Results: </strong>All serum proteins except WNT16 were lower after treatment with GH+CS, while about half increased after celecoxib. Serum IL-6 was significantly reduced (by 9%, P=0.001) after GH+CS, and satisfied the FDR<0.05 threshold. CCL20, CSF3, and WNT16 increased after celecoxib (by 7%, 9% and 9%, respectively, P<0.05), but these serum proteins were no longer statistically significant after controlling for multiple testing.</p><p><strong>Conclusion: </strong>The results of this study using samples from a previously conducted trial in OA patients, demonstrate that GH+CS reduces circulating IL-6, an inflammatory cytokine, but is otherwise comparable to celecoxib with regard to effects on other circulating protein biomarkers.</p>","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36857559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Mitigation of radiation induced gastrointestinal system injury using resveratrol or alpha-lipoic acid: A pilot histopathological study. 使用白藜芦醇或α-硫辛酸减轻辐射诱导的胃肠系统损伤:一项初步组织病理学研究。
Q2 Medicine Pub Date : 2019-11-11 DOI: 10.2174/1871523018666191111124028
Bagher Farhood, G. Hassanzadeh, P. Amini, Dheyauldeen Shabeeb, A. Musa, Ehsan Khodamoradi, M. Mohseni, A. Aliasgharzadeh, Habiballah Moradi, M. Najafi
AIMIn this study, we aimed to determine possible mitigation of radiation-induced toxicities in the duodenum, jejunum and colon using post-exposure treatment with resveratrol and alpha-lipoic acid.BACKGROUNDAfter the bone marrow, gastrointestinal system toxicity is the second critical cause of death following whole body exposure to radiation. Its side effects are responsible for reducing the quality of life of patients who had undergone radiotherapy. Resveratrol has an antioxidant effect and stimulates DNA damage responses (DDRs). Alpha-lipoic acid neutralizes free radicals via recycling of ascorbic acid and alpha-tocopherol.OBJECTIVEThis study is a pilot investigation of mitigation of enteritis using resveratrol and alpha-lipoic acid following histopathological study.METHOD60 male mice were randomly assigned to six groups; control, resveratrol treatment, alpha-lipoic acid treatment, whole body irradiation, irradiation plus resveratrol, and irradiation plus alpha-lipoic acid. The mice were irradiated with a single dose of 7 Gy from a cobalt-60 gamma ray source. Treatment with resveratrol or alpha-lipoic acid started 24 h after irradiation and continued for 4 weeks. All mice were sacrificed after 30 days for histopathological evaluation of radiation-induced toxicities in the duodenum, jejunum and colon.RESULTSExposure to radiation caused mild to severe damages to vessels, goblet cells and villous. It also led to significant infiltration of macrophages and leukocytes, especially in the colon. Both resveratrol and alpha-lipoic acid were able to mitigate morphological changes. However, they could not mitigate vascular injury.CONCLUSIONResveratrol and alpha-lipoic acid could mitigate radiation-induced injuries in small and large intestine. Comparison between these agents showed that resveratrol may be a more effective mitigator compared to alpha-lipoic acid.
目的在本研究中,我们旨在确定使用白藜芦醇和α-硫辛酸暴露后治疗对十二指肠、空肠和结肠辐射诱导毒性的可能缓解作用。背景胃肠道系统毒性是继骨髓之后的第二大致死原因,仅次于全身辐射。它的副作用降低了接受放射治疗的患者的生活质量。白藜芦醇具有抗氧化作用并刺激DNA损伤反应(DDRs)。α-硫辛酸通过抗坏血酸和α-生育酚的回收来中和自由基。目的本研究是在组织病理学研究后使用白藜芦醇和α-硫油酸缓解肠炎的初步研究。方法将60只雄性小鼠随机分为6组;对照、白藜芦醇治疗、α-硫辛酸治疗、全身照射、照射加白藜芦醇和照射加α-硫油酸。用钴-60伽马射线源的单剂量7Gy照射小鼠。用白藜芦醇或α-硫辛酸的治疗在照射后24小时开始,并持续4周。30天后处死所有小鼠,对十二指肠、空肠和结肠中辐射诱导的毒性进行组织病理学评估。结果暴露于辐射对血管、杯状细胞和绒毛造成轻度至重度损伤。它还导致巨噬细胞和白细胞的显著浸润,尤其是在结肠中。白藜芦醇和α-硫辛酸都能减轻形态学变化。然而,它们不能减轻血管损伤。结论白藜芦醇和α-硫辛酸可减轻辐射对小肠和大肠的损伤。这些药物之间的比较表明,与α-硫辛酸相比,白藜芦醇可能是一种更有效的缓解剂。
{"title":"Mitigation of radiation induced gastrointestinal system injury using resveratrol or alpha-lipoic acid: A pilot histopathological study.","authors":"Bagher Farhood, G. Hassanzadeh, P. Amini, Dheyauldeen Shabeeb, A. Musa, Ehsan Khodamoradi, M. Mohseni, A. Aliasgharzadeh, Habiballah Moradi, M. Najafi","doi":"10.2174/1871523018666191111124028","DOIUrl":"https://doi.org/10.2174/1871523018666191111124028","url":null,"abstract":"AIM\u0000In this study, we aimed to determine possible mitigation of radiation-induced toxicities in the duodenum, jejunum and colon using post-exposure treatment with resveratrol and alpha-lipoic acid.\u0000\u0000\u0000BACKGROUND\u0000After the bone marrow, gastrointestinal system toxicity is the second critical cause of death following whole body exposure to radiation. Its side effects are responsible for reducing the quality of life of patients who had undergone radiotherapy. Resveratrol has an antioxidant effect and stimulates DNA damage responses (DDRs). Alpha-lipoic acid neutralizes free radicals via recycling of ascorbic acid and alpha-tocopherol.\u0000\u0000\u0000OBJECTIVE\u0000This study is a pilot investigation of mitigation of enteritis using resveratrol and alpha-lipoic acid following histopathological study.\u0000\u0000\u0000METHOD\u000060 male mice were randomly assigned to six groups; control, resveratrol treatment, alpha-lipoic acid treatment, whole body irradiation, irradiation plus resveratrol, and irradiation plus alpha-lipoic acid. The mice were irradiated with a single dose of 7 Gy from a cobalt-60 gamma ray source. Treatment with resveratrol or alpha-lipoic acid started 24 h after irradiation and continued for 4 weeks. All mice were sacrificed after 30 days for histopathological evaluation of radiation-induced toxicities in the duodenum, jejunum and colon.\u0000\u0000\u0000RESULTS\u0000Exposure to radiation caused mild to severe damages to vessels, goblet cells and villous. It also led to significant infiltration of macrophages and leukocytes, especially in the colon. Both resveratrol and alpha-lipoic acid were able to mitigate morphological changes. However, they could not mitigate vascular injury.\u0000\u0000\u0000CONCLUSION\u0000Resveratrol and alpha-lipoic acid could mitigate radiation-induced injuries in small and large intestine. Comparison between these agents showed that resveratrol may be a more effective mitigator compared to alpha-lipoic acid.","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42385279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Synthesis and Biological Activity of a Bis-steroid-methanocyclobuta-naphthalene-dione Derivative against Ischemia/Reperfusion Injury via Calcium Channel Activation 双甾体-甲烷环丁烷-萘-二酮衍生物的合成及其通过钙通道激活抗缺血/再灌注损伤的生物活性
Q2 Medicine Pub Date : 2019-10-03 DOI: 10.2174/1871523018666191003152854
Figueroa‐Valverde Lauro, D. Francisco, Rosas-Nexticapa Marcela, Mateu-Armand Virginia, Garcimarero-Espino E. Alejandra, López-Ramos Maria, Hau-Heredia Lenin, Borges-Ballote Yaritza, Cabrera-Tuz Jhair
Background: There is some experimental data on the effect exerted by some steroid derivatives against ischemia/reperfusion injury; however, the molecular mechanism is very confusing, perhaps this phenomenon could be due to the protocols used and/or differences in the chemical structure of each one of the steroid derivatives. Objectives: The aim of this study was to synthesize a new bis-steroid-methanocyclobuta-naphthalene-dione derivative using some tools chemical. Methodology: The biological activity exerted by the bis-steroid-methanocyclobuta-naphthalene-dione derivative against ischemia/reperfusion injury was evaluated in an isolated heart model using noradrenaline, milrinone, dobutamine, levosimendan, and Bay-K-8644 as controls. In addition, other alternative experiments were carried out to evaluate the biological activity induced by the bis-steroid-methanocyclobuta-naphthalene-dione derivative against left ventricular pressure in the absence or presence of nifedipine. Results: The results showed that 1) the bis-steroid-methanocyclobuta-naphthalene-dione derivative significantly decreases the ischemia-reperfusion injury translated as a decrease in the the infarct area in a similar manner to levosimendan drug; 2) both bis-steroid-methanocyclobuta-naphthalene-dione and Bay-K-8644 increase the left ventricular pressure and 3) the biological activity exerted by bis-steroid-methanocyclobuta-naphthalene-dione derivative against left ventricular pressure is inhibited by nifedipine. Conclusion: In conclusion, the bis-steroid-methanocyclobuta-naphthalene-dione derivative decreases the area of infarction and increases left ventricle pressure via calcium channels activation; this phenomenon could constitute a new therapy for ischemia/reperfusion injury.
背景:一些类固醇衍生物对缺血/再灌注损伤的作用有一些实验数据;然而,分子机制非常令人困惑,也许这种现象可能是由于所使用的方案和/或每种类固醇衍生物的化学结构不同。目的:利用化学工具合成一种新的双甾体甲环氯丁萘二酮衍生物。方法:以去甲肾上腺素、米力农、多巴酚丁胺、左西孟旦和Bay-K-8644为对照,在离体心脏模型中评估双类固醇甲环氯丁萘二酮衍生物对缺血/再灌注损伤的生物活性。此外,还进行了其他替代实验,以评估在不存在或存在硝苯地平的情况下,双类固醇甲环氯丁萘二酮衍生物对左心室压力诱导的生物活性。结果:1)双甾体甲环氯丁萘二酮衍生物显著减少缺血再灌注损伤,即梗死面积的减少,其作用方式与左西孟旦药物相似;2) 双甾体甲环氯丁萘二酮和Bay-K-8644均能提高左心室压;3)硝苯地平可抑制双甾体甲环氯丁萘二酮衍生物对左心室压的生物活性。结论:双甾体甲环氯丁萘二酮衍生物通过激活钙通道,减少梗死面积,增加左心室压;这一现象可能为缺血/再灌注损伤提供一种新的治疗方法。
{"title":"Synthesis and Biological Activity of a Bis-steroid-methanocyclobuta-naphthalene-dione Derivative against Ischemia/Reperfusion Injury via Calcium Channel Activation","authors":"Figueroa‐Valverde Lauro, D. Francisco, Rosas-Nexticapa Marcela, Mateu-Armand Virginia, Garcimarero-Espino E. Alejandra, López-Ramos Maria, Hau-Heredia Lenin, Borges-Ballote Yaritza, Cabrera-Tuz Jhair","doi":"10.2174/1871523018666191003152854","DOIUrl":"https://doi.org/10.2174/1871523018666191003152854","url":null,"abstract":"Background: There is some experimental data on the effect exerted by some steroid derivatives against ischemia/reperfusion injury; however, the molecular mechanism is very confusing, perhaps this phenomenon could be due to the protocols used and/or differences in the chemical structure of each one of the steroid derivatives. Objectives: The aim of this study was to synthesize a new bis-steroid-methanocyclobuta-naphthalene-dione derivative using some tools chemical. Methodology: The biological activity exerted by the bis-steroid-methanocyclobuta-naphthalene-dione derivative against ischemia/reperfusion injury was evaluated in an isolated heart model using noradrenaline, milrinone, dobutamine, levosimendan, and Bay-K-8644 as controls. In addition, other alternative experiments were carried out to evaluate the biological activity induced by the bis-steroid-methanocyclobuta-naphthalene-dione derivative against left ventricular pressure in the absence or presence of nifedipine. Results: The results showed that 1) the bis-steroid-methanocyclobuta-naphthalene-dione derivative significantly decreases the ischemia-reperfusion injury translated as a decrease in the the infarct area in a similar manner to levosimendan drug; 2) both bis-steroid-methanocyclobuta-naphthalene-dione and Bay-K-8644 increase the left ventricular pressure and 3) the biological activity exerted by bis-steroid-methanocyclobuta-naphthalene-dione derivative against left ventricular pressure is inhibited by nifedipine. Conclusion: In conclusion, the bis-steroid-methanocyclobuta-naphthalene-dione derivative decreases the area of infarction and increases left ventricle pressure via calcium channels activation; this phenomenon could constitute a new therapy for ischemia/reperfusion injury.","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871523018666191003152854","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42872916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Tegaserod for the Treatment of Irritable Bowel Syndrome 替加塞罗德治疗肠易激综合征
Q2 Medicine Pub Date : 2019-09-11 DOI: 10.2174/1871523018666190911121306
V. N. Madia, A. Messore, Francesco Saccoliti, V. Tudino, A. De Leo, D. De Vita, Martina Bortolami, L. Scipione, I. Pindinello, R. Costi, R. Di Santo
Background: Tegaserod (Zelnorm®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C). Objective: The authors provide the reader with a better understanding on tegaserod mechanism of action, on its pharmacodynamics and pharmacokinetic properties, on safety and tolerability, with a summary of the key published clinical trials conducted in patients with irritable bowel syndrome (IBS). Its effects on colon inflammation have also been described. Results: Tegaserod was withdrawn in 2007 due to increased risks of cardiovascular adverse effects. The manufacturer denied this, because pre-existing cardiovascular disease or risk factors were attributed to all affected patients. Thus, no causal relationship between tegaserod use and cardiovascular events was clearly shown. A matched case-control study of tegaserod-treated with untreated patients found no association between tegaserod and adverse cardiovascular outcomes. Despite its adverse effects, tegaserod resulted to be effective in treating chronic constipation in adult women aged < 65 years with IBS-C, while the safety and effectiveness of tegaserod in men with IBS-C have not been established. Conclusion: Tegaserod was resubmitted to the Food and Drug Administration in 2018 for use in a low-risk population. Moreover, tegaserod has also been shown to improve symptoms, enhance gastric accommodation and significantly attenuate visceral pain arising from the colon in functional dyspepsia patients. Treatment with tegaserod seems also to exert a protective effect in inflamed colons, reducing the severity of colitis in animal models.
背景:Tegaserod (Zelnorm®)是一种5-羟色胺(5-羟色胺)4型受体激动剂,用于治疗与肠易激综合征合并便秘(IBS-C)相关的下胃肠道运动障碍。目的:通过对已发表的针对肠易激综合征(IBS)患者的主要临床试验的总结,使读者对泰加塞罗德的作用机制、药效学和药代动力学特性、安全性和耐受性有更深入的了解。它对结肠炎症的影响也被描述过。结果:Tegaserod因心血管不良反应风险增加于2007年被停药。制造商否认了这一点,因为所有受影响的患者都有先前存在的心血管疾病或危险因素。因此,tegaserod的使用与心血管事件之间没有明确的因果关系。一项对替加塞罗德治疗与未治疗患者的配对病例对照研究发现,替加塞罗德与不良心血管结局之间没有关联。尽管有不良反应,但泰加塞罗德对65岁以下IBS-C成年女性慢性便秘有效,而泰加塞罗德对IBS-C男性的安全性和有效性尚未确定。结论:Tegaserod于2018年重新提交给美国食品和药物管理局,用于低风险人群。此外,tegaserod也被证明可以改善功能性消化不良患者的症状,增强胃调节,并显著减轻由结肠引起的内脏疼痛。用tegaserod治疗似乎对发炎的结肠也有保护作用,在动物模型中降低结肠炎的严重程度。
{"title":"Tegaserod for the Treatment of Irritable Bowel Syndrome","authors":"V. N. Madia, A. Messore, Francesco Saccoliti, V. Tudino, A. De Leo, D. De Vita, Martina Bortolami, L. Scipione, I. Pindinello, R. Costi, R. Di Santo","doi":"10.2174/1871523018666190911121306","DOIUrl":"https://doi.org/10.2174/1871523018666190911121306","url":null,"abstract":"Background: Tegaserod (Zelnorm®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C). Objective: The authors provide the reader with a better understanding on tegaserod mechanism of action, on its pharmacodynamics and pharmacokinetic properties, on safety and tolerability, with a summary of the key published clinical trials conducted in patients with irritable bowel syndrome (IBS). Its effects on colon inflammation have also been described. Results: Tegaserod was withdrawn in 2007 due to increased risks of cardiovascular adverse effects. The manufacturer denied this, because pre-existing cardiovascular disease or risk factors were attributed to all affected patients. Thus, no causal relationship between tegaserod use and cardiovascular events was clearly shown. A matched case-control study of tegaserod-treated with untreated patients found no association between tegaserod and adverse cardiovascular outcomes. Despite its adverse effects, tegaserod resulted to be effective in treating chronic constipation in adult women aged < 65 years with IBS-C, while the safety and effectiveness of tegaserod in men with IBS-C have not been established. Conclusion: Tegaserod was resubmitted to the Food and Drug Administration in 2018 for use in a low-risk population. Moreover, tegaserod has also been shown to improve symptoms, enhance gastric accommodation and significantly attenuate visceral pain arising from the colon in functional dyspepsia patients. Treatment with tegaserod seems also to exert a protective effect in inflamed colons, reducing the severity of colitis in animal models.","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871523018666190911121306","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48695366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
In silico and in vitro Study of the Inhibitory Effect of Anti-inflammatory Drug Betamethasone on Two Lipases 抗炎药倍他米松对两种脂肪酶抑制作用的计算机及体外研究
Q2 Medicine Pub Date : 2019-09-06 DOI: 10.2174/1871523018666190906165944
Nia Samira, Benarous Khedidja, Abdelalim Fatima Zahra, Chellali Khadidja Nour Elyakine, Yousfi Mohamed
Background For the first time, the anti-inflammatory drug betamethasone is investigated for its inhibitory activity against lipase. Objective This work aims to demonstrate the in vitro and in silico inhibitory effect of the anti-inflammatory drug betamethasone on the enzymatic activity of two lipases. Methods In vitro study using p-nitrophenyllaurate as lipase substrate is used to determine inhibition potency. Molecular Docking is performed using the Autodock Vina for drug molecule and two enzymes Candida rugosa lipase and human pancreatic lipase. Results Betamethasone represents a moderate inhibition effect with a value of IC50 of 0.36±0.01 mg/ml. Molecular docking allowed us to understand inhibitory – enzyme interactions and to confirm in vitro obtained results. Conclusion These experiments showed that betamethasone can be used in the treatment of diseases related to lipase activity.
背景首次研究了抗炎药物倍他米松对脂肪酶的抑制作用。目的研究抗炎药倍他米松对两种脂肪酶活性的体外和体内抑制作用。方法采用对硝基苯月桂酸酯作为脂肪酶底物的体外实验,测定其抑制效力。利用Autodock Vina对药物分子与念珠菌脂肪酶和人胰脂肪酶两种酶进行分子对接。结果倍他米松具有中等抑制作用,IC50值为0.36±0.01 mg/ml。分子对接使我们能够了解抑制酶的相互作用,并确认体外获得的结果。结论倍他米松可用于脂肪酶活性相关疾病的治疗。
{"title":"In silico and in vitro Study of the Inhibitory Effect of Anti-inflammatory Drug Betamethasone on Two Lipases","authors":"Nia Samira, Benarous Khedidja, Abdelalim Fatima Zahra, Chellali Khadidja Nour Elyakine, Yousfi Mohamed","doi":"10.2174/1871523018666190906165944","DOIUrl":"https://doi.org/10.2174/1871523018666190906165944","url":null,"abstract":"Background For the first time, the anti-inflammatory drug betamethasone is investigated for its inhibitory activity against lipase. Objective This work aims to demonstrate the in vitro and in silico inhibitory effect of the anti-inflammatory drug betamethasone on the enzymatic activity of two lipases. Methods In vitro study using p-nitrophenyllaurate as lipase substrate is used to determine inhibition potency. Molecular Docking is performed using the Autodock Vina for drug molecule and two enzymes Candida rugosa lipase and human pancreatic lipase. Results Betamethasone represents a moderate inhibition effect with a value of IC50 of 0.36±0.01 mg/ml. Molecular docking allowed us to understand inhibitory – enzyme interactions and to confirm in vitro obtained results. Conclusion These experiments showed that betamethasone can be used in the treatment of diseases related to lipase activity.","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871523018666190906165944","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43759646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meet Our Editorial Board Member 见见我们的编辑委员会成员
Q2 Medicine Pub Date : 2019-07-24 DOI: 10.2174/187152301802190625111906
F. Odabasoglu
{"title":"Meet Our Editorial Board Member","authors":"F. Odabasoglu","doi":"10.2174/187152301802190625111906","DOIUrl":"https://doi.org/10.2174/187152301802190625111906","url":null,"abstract":"","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/187152301802190625111906","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46869430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New anti-inflammatory Triterpene Esters and glycosides from Alstonia scholaris. 新的抗炎三萜酯和糖苷。
Q2 Medicine Pub Date : 2019-07-24 DOI: 10.2174/1871523018666190724122406
N. Sultana, Muhammad Saleem Qazi, M. Kamal
Phytochemical studies on the ethanolic extract of aerial parts of Alstoniascholaris lead to the isolation of two new triterpenoid of the lanostanetype,lanosta 5ene,24-ethyl-3-O-β-D-glucopyranoside(1), lanosta,5ene,24-ethyl-3-O-β-D-glucopyranosideester(2)and new ursane type triterpenoidmethylester, 12-ursene-2,3,18,19-tetrol,28 acetate (nighascholarene)(3),together with seven known triterpenes, betuline,triterpeneof the lupane type, alstoprenyol(4), 3β-hydroxy-28-β-acetoxy-5-olea triterpene (5),α-amyrin acetate (6), α-amyrin (7), lupeol acetate (8), 3β-hydroxy-24-nor-urs-4,12,28-triene triterpene (9) and ursolic acid (l0). The triterpenoid structures of these colorless compounds were deduced from the 1H and 13C-NMR data, and in particular from the application of two-dimensional 1H, 13C correlation experiments as well as by comparison with reported literature data.This study deals with isolation and structural elucidation ofnaturalnewtriterpenoidestersandglycosides with anti-inflammatory activity.
通过对白石桐属植物地上部分乙醇提取物的植物化学研究,分离出两种新的羊毛甾烷型三萜,羊毛石桐属5ene,24-乙基-3- o -β- d -葡萄糖吡喃葡萄糖苷(1),羊毛石桐属5ene,24-乙基-3- o -β- d -葡萄糖吡喃葡萄糖苷(2)和新的熊甾型三萜-甲基lester, 12-熊甾-2,3,18,19-四醇,28乙酸(夜酪烯)(3),以及7种已知的三萜,白桦碱,狼烷型三萜,蛇烯醇(4)。3β-羟基-28-β-乙酰氧基-5-油橄榄三萜(5),α-醋酸amyrin (6), α-amyrin(7),醋酸lupeol (8), 3β-羟基-24-no -urs-4,12,28-triene三萜(9)和熊果酸(10)。这些无色化合物的三萜结构是通过1H和13C- nmr数据,特别是通过二维1H, 13C相关实验的应用以及与文献数据的比较推断出来的。本研究对具有抗炎活性的天然新型三萜苷类化合物进行了分离和结构鉴定。
{"title":"New anti-inflammatory Triterpene Esters and glycosides from Alstonia scholaris.","authors":"N. Sultana, Muhammad Saleem Qazi, M. Kamal","doi":"10.2174/1871523018666190724122406","DOIUrl":"https://doi.org/10.2174/1871523018666190724122406","url":null,"abstract":"Phytochemical studies on the ethanolic extract of aerial parts of Alstoniascholaris lead to the isolation of two new triterpenoid of the lanostanetype,lanosta 5ene,24-ethyl-3-O-β-D-glucopyranoside(1), lanosta,5ene,24-ethyl-3-O-β-D-glucopyranosideester(2)and new ursane type triterpenoidmethylester, 12-ursene-2,3,18,19-tetrol,28 acetate (nighascholarene)(3),together with seven known triterpenes, betuline,triterpeneof the lupane type, alstoprenyol(4), 3β-hydroxy-28-β-acetoxy-5-olea triterpene (5),α-amyrin acetate (6), α-amyrin (7), lupeol acetate (8), 3β-hydroxy-24-nor-urs-4,12,28-triene triterpene (9) and ursolic acid (l0). The triterpenoid structures of these colorless compounds were deduced from the 1H and 13C-NMR data, and in particular from the application of two-dimensional 1H, 13C correlation experiments as well as by comparison with reported literature data.This study deals with isolation and structural elucidation ofnaturalnewtriterpenoidestersandglycosides with anti-inflammatory activity.","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871523018666190724122406","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45108575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1